Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies. [electronic resource] by
- Norris, Stephen
- Ramael, Steven
- Ikushima, Ippei
- Haazen, Wouter
- Harada, Akiko
- Moschetti, Viktoria
- Imazu, Susumu
- Reilly, Paul A
- Lang, Benjamin
- Stangier, Joachim
- Glund, Stephan
Producer: 20180412
In:
British journal of clinical pharmacology vol. 83
Availability: No items available.
|
|
5.
|
|
|
6.
|
A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies. [electronic resource] by
- Beliard, Roland
- Waegemans, Tony
- Notelet, Dominique
- Massad, Léna
- Dhainaut, Frédéric
- Romeuf, Christophe de
- Guemas, Eric
- Haazen, Wouter
- Bourel, Dominique
- Teillaud, Jean-Luc
- Prost, Jean-François
Producer: 20080611
In:
British journal of haematology vol. 141
Availability: No items available.
|
|
7.
|
Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study. [electronic resource] by
- Glund, Stephan
- Stangier, Joachim
- van Ryn, Joanne
- Schmohl, Michael
- Moschetti, Viktoria
- Haazen, Wouter
- De Smet, Marina
- Gansser, Dietmar
- Norris, Stephen
- Lang, Benjamin
- Reilly, Paul
- Kreuzer, Jörg
Producer: 20170816
In:
Clinical pharmacokinetics vol. 56
Availability: No items available.
|
|
8.
|
Restarting Dabigatran Etexilate 24 h After Reversal With Idarucizumab and Redosing Idarucizumab in Healthy Volunteers. [electronic resource] by
- Glund, Stephan
- Stangier, Joachim
- van Ryn, Joanne
- Schmohl, Michael
- Moschetti, Viktoria
- Haazen, Wouter
- De Smet, Marina
- Gansser, Dietmar
- Norris, Stephen
- Lang, Benjamin
- Reilly, Paul
- Kreuzer, Jörg
Producer: 20180611
In:
Journal of the American College of Cardiology vol. 67
Availability: No items available.
|
|
9.
|
Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial. [electronic resource] by
- Frenck, Robert W
- Ervin, John
- Chu, Laurence
- Abbanat, Darren
- Spiessens, Bart
- Go, Oscar
- Haazen, Wouter
- van den Dobbelsteen, Germie
- Poolman, Jan
- Thoelen, Stefan
- Ibarra de Palacios, Patricia
Producer: 20200608
In:
The Lancet. Infectious diseases vol. 19
Availability: No items available.
|
|
10.
|
Pharmacokinetics and Pharmacodynamics of Omarigliptin, a Once-Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitor, After Single and Multiple Doses in Healthy Subjects. [electronic resource] by
- Krishna, Rajesh
- Addy, Carol
- Tatosian, Daniel
- Glasgow, Xiaoli S
- Gendrano Iii, Isaias Noel
- Robberechts, Martine
- Haazen, Wouter
- de Hoon, J N
- Depré, Marleen
- Martucci, Ashley
- Peng, Joanna Z
- Johnson-Levonas, Amy O
- Wagner, John A
- Stoch, S Aubrey
Producer: 20170814
In:
Journal of clinical pharmacology vol. 56
Availability: No items available.
|
|
11.
|
Minimal effects of ritonavir and efavirenz on the pharmacokinetics of raltegravir. [electronic resource] by
- Iwamoto, Marian
- Wenning, Larissa A
- Petry, Amelia S
- Laethem, Martine
- De Smet, Marina
- Kost, James T
- Breidinger, Sheila A
- Mangin, Eric C
- Azrolan, Neal
- Greenberg, Howard E
- Haazen, Wouter
- Stone, Julie A
- Gottesdiener, Keith M
- Wagner, John A
Producer: 20090127
In:
Antimicrobial agents and chemotherapy vol. 52
Availability: No items available.
|